» Articles » PMID: 20225066

Reciprocal Granzyme/perforin-mediated Death of Human Regulatory and Responder T Cells is Regulated by Interleukin-2 (IL-2)

Overview
Specialty General Medicine
Date 2010 Mar 13
PMID 20225066
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Human CD4(+)CD25(high)FOXP3(+) T regulatory cells (Treg) can suppress responder T cell (RC) functions by various mechanisms. In co-cultures of Treg and autologous activated RC, both cell subsets up-regulate the expression of granzymes and perforin, which might contribute to Treg-mediated suppression. Here, we investigate the sensitivity and resistance of Treg and RC to granzyme/perforin-mediated death. CD4(+)CD25(neg) RC were single cell-sorted from the peripheral blood of 25 cancer patients and 15 normal controls. These RC were carboxyfluorescein diacetate succinimidyl ester (CFSE) labeled and co-cultured with autologous CD4(+)CD25(high)FOXP3(+) Treg +/- 150 or +/-1,000 IU/mL of interleukin-2 (IL-2) to evaluate suppression of RC proliferation. In addition, survival of the cells co-cultured for 24 h and 5 days was measured using a flow-based cytotoxicity assay. Freshly isolated Treg and RC expressed granzyme A (GrA), granzyme B (GrB), and perforin. Percentages of positive cells were higher in cancer patients than controls (p < 0.01) and increased upon OKT3 and IL-2 stimulation. Treg, co-cultured with RC at 150 IU/mL of IL-2, no longer expressed cytotoxins and became susceptible to RC-mediated, granzyme/perforin-dependent death. However, in co-cultures with 1,000 IU/mL of IL-2, Treg became resistant to apoptosis and induced GrB-dependent, perforin-independent death of RC. When the GrB inhibitor I or GrB-specific and GrA-specific small inhibitory ribonucleic acids were used to block the granzyme pathway in Treg, RC death, and Treg-mediated suppression of RC, proliferation were significantly inhibited. Human CD4(+)CD25(high) Treg and CD4(+)CD25(neg) RC reciprocally regulate death/growth arrest by differentially utilizing the granzyme-perforin pathway depending on IL-2 concentrations.

Citing Articles

Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications.

Zheng X, Sun R, Wei T Front Immunol. 2024; 15:1438235.

PMID: 39290709 PMC: 11405226. DOI: 10.3389/fimmu.2024.1438235.


Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense.

Yue Y, Ren Y, Lu C, Li P, Zhang G Front Immunol. 2024; 15:1444533.

PMID: 39144146 PMC: 11323565. DOI: 10.3389/fimmu.2024.1444533.


Immunomodulatory effects of extracellular vesicles in glioblastoma.

Low J, Sulaiman S, Johdi N, Abu N Front Cell Dev Biol. 2022; 10:996805.

PMID: 36467419 PMC: 9708723. DOI: 10.3389/fcell.2022.996805.


Breast Cancer Cell-Derived Adenosine Enhances Generation and Suppressor Function of Human Adaptive Regulatory T Cells.

Mandapathil M, Szczepanski M, Jackson E, Lang S, Whiteside T J Pers Med. 2021; 11(8).

PMID: 34442398 PMC: 8401826. DOI: 10.3390/jpm11080754.


Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment.

Wang W, Zou R, Qiu Y, Liu J, Xin Y, He T Front Immunol. 2021; 12:670324.

PMID: 33868318 PMC: 8047302. DOI: 10.3389/fimmu.2021.670324.


References
1.
Givan A, Fisher J, Waugh M, Ernstoff M, Wallace P . A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods. 1999; 230(1-2):99-112. DOI: 10.1016/s0022-1759(99)00136-2. View

2.
Mandapathil M, Szczepanski M, Szajnik M, Ren J, Lenzner D, Jackson E . Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin Cancer Res. 2009; 15(20):6348-57. PMC: 2763335. DOI: 10.1158/1078-0432.CCR-09-1143. View

3.
Smyth M, Kelly J, Sutton V, Davis J, Browne K, Sayers T . Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol. 2001; 70(1):18-29. View

4.
Shevach E . CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002; 2(6):389-400. DOI: 10.1038/nri821. View

5.
Levings M, Sangregorio R, Sartirana C, Moschin A, Battaglia M, Orban P . Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med. 2002; 196(10):1335-46. PMC: 2193983. DOI: 10.1084/jem.20021139. View